Oseltamivir® News 

Early Tamiflu Might Benefit Transplant Patients With H1N1 Flu
Found on 09 Jul 2010 08:59 GMT
Title: Early Tamiflu Might Benefit Transplant Patients With H1N1 Flu
Category: Health News
Created: 7/8/2010 8:10:00 PM
Last Editorial Review: 7/9/2010

Review Questions Tamiflu's Effectiveness
Found on 09 Dec 2009 07:59 GMT
Title: Review Questions Tamiflu's Effectiveness
Category: Health News
Created: 12/8/2009 4:10:00 PM
Last Editorial Review: 12/9/2009

Tamiflu-Resistant Swine Flu Found in Canadian Father
Found on 12 Nov 2009 07:59 GMT
Title: Tamiflu-Resistant Swine Flu Found in Canadian Father
Category: Health News
Created: 11/11/2009 4:10:00 PM
Last Editorial Review: 11/12/2009

Oseltamivir-resistant influenza viruses A (H1N1), Norway, 2007-08.(RESEARCH)(...
In Norway in January 2008, unprecedented levels of oseltamivir resistance were found in 12 of 16 influenza viruses A (H1N1) tested. To investigate the epidemiologic and clinical characteristics of these viruses, we used sequence analysis to test all available subtype H1N1 viruses from the 2007-08

Publication: Emerging Infectious Diseases

Oseltamivir
Oseltamivir has come into the limelight after the onset of H1N1-Influenza A ('swine flu') pandemic this year. Influenza infections continue to occur worldwide with adverse outcomes in terms of morbidity and mortality in those who are infected. [1] Oseltamivir is a potent selective inhibitor of the

Publication: Journal of Postgraduate Medicine

Oseltamivir (Tamiflu) Resistance in Seasonal Influenza A (H1N1) Viruses.(Report)
Oseltamivir (Tamiflu) Resistance in Seasonal Influenza A (H1N1) Viruses Abstract & commentary By Mary-Louise Scully, MD, Sansum-Santa Barbara Medical Foundation Clinic, Santa Barbara, CA. Dr. Scully reports no financial relationships relevant to this field of study. This article originally appeared

Publication: Hospital Medicine Alert

Oseltamivir- and amantadine-resistant influenza viruses A (H1N1).(DISPATCHES)
A high rate of oseltamivir resistance in seasonal influenza virus A (H1N1) infection was reported in Europe in the winter of 2007-08 (1). Of subtype H1N1 isolates tested in 18 European countries, 59 (13.5%) of 437 were resistant to oseltamivir and carried the substitution of histidine by tyrosine

Publication: Emerging Infectious Diseases

Oseltamivir Phosphate Capsules (Tamiflu-Roche Pharmaceuticals).
Pharmacology Update Oseltamivir Phosphate Capsules (TamifluRoche Pharmaceuticals) By William T. Elliott, MD, FACP, and James Chan, PharmD, PhD In october, the fda approved oseltamvir (tamifluRoche), the second neuraminidase inhibitor for the treatment of influenza. This comes three months after the

Publication: Internal Medicine Alert

Oseltamivir prescribing in pharmacy-benefits database, United States, 2004-20...
We reviewed information from a US pharmacy benefits manager database from 2004 through 2005 during periods with little influenza activity. We calculated rates of oseltamivir prescriptions to enrollees. Prescription rates increased significantly from 27.3/100,000 in 2004 to 134/100,000 in 2005 (p50

Publication: Emerging Infectious Diseases

Oseltamivir (Tamiflu) resistance in seasonal influenza A (H1N1) viruses.(Report)
Oseltamivir (Tamiflu) Resistance in Seasonal Influenza A (H1N1) Viruses Abstract & Commentary By Mary-Louise Scully, MD, Sansum-Santa Barbara Medical Foundation Clinic, Santa Barbara, CA. Dr. Scully reports no financial relationships relevant to this field of study. This article originally appeared

Publication: Infectious Disease Alert

Oseltamivir Phosphate Capsules (Tamiflu-Roche Pharmaceuticals).
IN OCTOBER, THE FDA APPROVED OSELTAMVIR (TAMI-flu-Roche), the second neuraminidase inhibitor for the treatment of influenza. This comes three months after the FDA approved zanamivir (Relenza) (Intern Med Alert 1999;21:133). The major difference between these agents is the route of

Publication: Internal Medicine Alert

Oseltamivir (Tamiflu) Resistance in Seasonal Influenza A (H1N1) Viruses.
Oseltamivir (Tamiflu) Resistance in Seasonal Influenza A (H1N1) Viruses Abstract & Commentary By Mary-Louise Scully, MD Sansum-Santa Barbara Medical Foundation Clinic, Santa Barbara, CA. Dr. Scully reports no financial relationships relevant to this field of study. Synopsis: Preliminary data

Publication: Travel Medicine Advisor

Oseltamivir Resistance and the H274Y Neuraminidase Mutation in Seasonal, Pand...
The neuraminidase inhibitors (NAIs) are a class of anti-influenza drugs that were rationally designed using the 3-dimensional structure of the influenza neuraminidase.[1] The compounds bind to the enzyme active site of the neuraminidase glycoprotein of influenza A and B viruses and inhibit the

Publication: Drugs